(Molecular Biology Thematic Programme of Semmelweis University)
(Open access funding provided by Semmelweis University)
Subjects:
Clinical medicine
Recent findings show that single, non-neuronal cells are also able to learn signalling
responses developing cellular memory. In cellular learning nodes of signalling networks
strengthen their interactions e.g. by the conformational memory of intrinsically disordered
proteins, protein translocation, miRNAs, lncRNAs, chromatin memory and signalling
cascades. This can be described by a generalized, unicellular Hebbian learning process,
where those signalling connections, which participate in learning, become stronger.
Here we review those scenarios, where cellular signalling is not only repeated in
a few times (when learning occurs), but becomes too frequent, too large, or too complex
and overloads the cell. This leads to desensitisation of signalling networks by decoupling
signalling components, receptor internalization, and consequent downregulation. These
molecular processes are examples of anti-Hebbian learning and ‘forgetting’ of signalling
networks. Stress can be perceived as signalling overload inducing the desensitisation
of signalling pathways. Ageing occurs by the summative effects of cumulative stress
downregulating signalling. We propose that cellular learning desensitisation, stress
and ageing may be placed along the same axis of more and more intensive (prolonged
or repeated) signalling. We discuss how cells might discriminate between repeated
and unexpected signals, and highlight the Hebbian and anti-Hebbian mechanisms behind
the fold-change detection in the NF- κ B signalling pathway. We list drug design methods
using Hebbian learning (such as chemically-induced proximity) and clinical treatment
modalities inducing (cancer, drug allergies) desensitisation or avoiding drug-induced
desensitisation. A better discrimination between cellular learning, desensitisation
and stress may open novel directions in drug design, e.g. helping to overcome drug
resistance.